AgingResearch.News
Frontiers in Gastroenterology

Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms

By Shannon Fernando, Joy Zhao, Kevan Josloff, Show 6 more authorsPriya Sehgal
Figure 1. Proposed algorithm for evaluation of gastrointestinal symptoms in patients with IBD who have initiated GLP-1RA therapy (40).
Open the figure at full size
Figure 1. Proposed algorithm for evaluation of gastrointestinal symptoms in patients with IBD who have initiated GLP-1RA therapy (40).Proposed algorithm for evaluation of gastrointestinal symptoms in patients with IBD who have initiated GLP-1RA therapy (40).Fernando et al.
ReviewInterventions
Paper

The paper

Shannon Fernando, Joy Zhao, Kevan Josloff, Show 6 more authorsPriya Sehgal

Thomas Jefferson University Hospital

Frontiers in Gastroenterology, 21 Aug 2026

doi.org/10.3389/fgstr.2026.1864456PubMed 42699172

More on GLP-1 receptor agonists